Added to YB: 2025-10-03
Pitch date: 2025-10-01
CLPT [bullish]
ClearPoint Neuro, Inc.
-39.82%
current return
Author Info
MVC Investing is a long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Sign up for the newsletter.
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$438.6M
Pitch Price
$21.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.80
P/E
-18.67
EV/Sales
12.70
Sector
Health Care Equipment and Supplies
Category
growth
M. V. Cunha | Portfolio Update – 09/30/2025 – Q3 Review: Added - ClearPoint Neuro, Inc.
CLPT added position: AMT-130 data validates platform as enabling infrastructure for CNS therapies - first visible proof concept works. Stock +58.5% on 29x volume. 60+ partnered programs, shift from speculative to validated platform. $600M market cap still values as niche medtech vs platform potential.
Read full article (2 min)